Graeme R. Robb

2.0k total citations
33 papers, 779 citations indexed

About

Graeme R. Robb is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Graeme R. Robb has authored 33 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Surgery and 6 papers in Organic Chemistry. Recurrent topics in Graeme R. Robb's work include Pancreatic function and diabetes (7 papers), Computational Drug Discovery Methods (5 papers) and Protein Structure and Dynamics (3 papers). Graeme R. Robb is often cited by papers focused on Pancreatic function and diabetes (7 papers), Computational Drug Discovery Methods (5 papers) and Protein Structure and Dynamics (3 papers). Graeme R. Robb collaborates with scholars based in United Kingdom, Sweden and United States. Graeme R. Robb's co-authors include Andrew G. Leach, Ed Griffen, Daniel J. Warner, Craig Johnstone, Andrew Harrison, Michael J. Waring, Darren McKerrecher, Jan Kihlberg, Richard A. Thompson and Alleyn T. Plowright and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Chemical Communications.

In The Last Decade

Graeme R. Robb

33 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme R. Robb United Kingdom 16 401 290 175 131 84 33 779
Patrizio Mattei Switzerland 16 462 1.2× 175 0.6× 201 1.1× 120 0.9× 135 1.6× 24 980
Christian Buning Germany 10 530 1.3× 341 1.2× 143 0.8× 140 1.1× 82 1.0× 12 795
Jacopo Sgrignani Italy 22 611 1.5× 203 0.7× 214 1.2× 120 0.9× 23 0.3× 61 1.2k
Rayomand J. Unwalla United States 19 428 1.1× 219 0.8× 395 2.3× 49 0.4× 51 0.6× 34 1.1k
Roberto Artali Italy 24 698 1.7× 84 0.3× 255 1.5× 82 0.6× 35 0.4× 70 1.2k
Inge Thøger Christensen Denmark 15 328 0.8× 179 0.6× 98 0.6× 46 0.4× 60 0.7× 18 603
Andreas Evers Germany 21 1.1k 2.9× 528 1.8× 170 1.0× 102 0.8× 281 3.3× 55 1.6k
Antonella Ciancetta Italy 22 896 2.2× 206 0.7× 344 2.0× 86 0.7× 22 0.3× 61 1.4k
Mario Cardozo United States 18 773 1.9× 233 0.8× 552 3.2× 46 0.4× 67 0.8× 31 1.4k
Christian Sköld Sweden 19 373 0.9× 177 0.6× 444 2.5× 165 1.3× 47 0.6× 36 932

Countries citing papers authored by Graeme R. Robb

Since Specialization
Citations

This map shows the geographic impact of Graeme R. Robb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme R. Robb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme R. Robb more than expected).

Fields of papers citing papers by Graeme R. Robb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme R. Robb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme R. Robb. The network helps show where Graeme R. Robb may publish in the future.

Co-authorship network of co-authors of Graeme R. Robb

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme R. Robb. A scholar is included among the top collaborators of Graeme R. Robb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme R. Robb. Graeme R. Robb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robb, Graeme R., et al.. (2024). Automated Adaptive Absolute Binding Free Energy Calculations. Journal of Chemical Theory and Computation. 8 indexed citations
2.
Mervin, Lewis, et al.. (2023). An industrial evaluation of proteochemometric modelling: Predicting drug-target affinities for kinases. SHILAP Revista de lepidopterología. 4. 100079–100079. 2 indexed citations
3.
Robb, Graeme R., et al.. (2023). Comparison of Receptor–Ligand Restraint Schemes for Alchemical Absolute Binding Free Energy Calculations. Journal of Chemical Theory and Computation. 19(12). 3686–3704. 21 indexed citations
4.
Smith, James M., Bernard Barlaam, David T. Beattie, et al.. (2023). Abstract 3088: Identification of a novel series of MTAP-selective PRMT5 inhibitors, and first disclosure of AZ-PRMT5i-1. Cancer Research. 83(7_Supplement). 3088–3088. 1 indexed citations
5.
Cumming, Iain, Sébastien L. Degorce, Anna Aagaard, et al.. (2022). Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors. Bioorganic & Medicinal Chemistry. 63. 116729–116729. 4 indexed citations
6.
Bodnarchuk, Michael S., et al.. (2021). Drugging the undruggable: a computational chemist's view of KRASG12C. RSC Medicinal Chemistry. 12(4). 609–614. 4 indexed citations
7.
Degorce, Sébastien L., Rana Anjum, Keith Dillman, et al.. (2018). Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4. Bioorganic & Medicinal Chemistry. 26(4). 913–924. 15 indexed citations
8.
Barlaam, Bernard, Elaine Cadogan, Andrew D. Campbell, et al.. (2018). Discovery of a Series of 3-Cinnoline Carboxamides as Orally Bioavailable, Highly Potent, and Selective ATM Inhibitors. ACS Medicinal Chemistry Letters. 9(8). 809–814. 19 indexed citations
9.
Krämer, Christian, Attilla Ting, Hao Zheng, et al.. (2017). Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA). Journal of Medicinal Chemistry. 61(8). 3277–3292. 67 indexed citations
10.
Raubo, Piotr, David Andrews, Graeme R. Robb, et al.. (2015). Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα). Bioorganic & Medicinal Chemistry Letters. 25(16). 3189–3193. 11 indexed citations
11.
Robb, Graeme R., Scott Boyd, Alexander G. Dossetter, et al.. (2015). Design of pyrazolo-pyrimidines as 11β-HSD1 inhibitors through optimisation of molecular electrostatic potential. MedChemComm. 6(5). 926–934. 4 indexed citations
12.
Waring, Michael J., Darren A.E. Cross, David Andrews, et al.. (2013). Abstract 2228: Phosphatidylinositol-4-kinase - Potent and selective inhibitors of PI4Kα and PI4Kβ.. Cancer Research. 73(8_Supplement). 2228–2228. 1 indexed citations
13.
Waring, Michael J., Scott Boyd, Leonie Campbell, et al.. (2013). Optimising pharmacokinetics of glucokinase activators with matched triplicate design sets – the discovery of AZD3651 and AZD9485. MedChemComm. 4(4). 663–663. 6 indexed citations
14.
Jurva, Ulrik, et al.. (2012). The discovery of a novel series of glucokinase activators based on a pyrazolopyrimidine scaffold. Bioorganic & Medicinal Chemistry Letters. 22(24). 7302–7305. 15 indexed citations
15.
Robb, Graeme R., et al.. (2012). A chemistry wiki to facilitate and enhance compound design in drug discovery. Drug Discovery Today. 18(3-4). 141–147. 10 indexed citations
16.
Waring, Michael J., Craig Johnstone, Darren McKerrecher, Kurt G. Pike, & Graeme R. Robb. (2011). Matrix-based multiparameter optimisation of glucokinase activators: the discovery of AZD1092. MedChemComm. 2(8). 775–775. 21 indexed citations
17.
Plowright, Alleyn T., et al.. (2011). Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle. Drug Discovery Today. 17(1-2). 56–62. 66 indexed citations
18.
Harrison, Andrew, et al.. (2002). In situ neutron diffraction studies of single crystals and powders during microwave irradiation. Faraday Discussions. 122. 363–379. 30 indexed citations
19.
Robb, Graeme R., Andrew Harrison, & A. Gavin Whittaker. (2002). Temperature-resolved, in-situ powder X-ray diffraction of silver iodide under microwave irradiation. 5(19). 135–135. 30 indexed citations
20.
Smith, Stephen A., et al.. (1989). Effects of BRL 35135, a beta-adrenoceptor agonist with novel selectivity, on glucose tolerance and insulin sensitivity in obese subjects.. PubMed. 13(6). 757–66. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizio Mattei Breakdown of academic impact, for papers by Christian Buning Breakdown of academic impact, for papers by Jacopo Sgrignani Breakdown of academic impact, for papers by Rayomand J. Unwalla Breakdown of academic impact, for papers by Roberto Artali Breakdown of academic impact, for papers by Inge Thøger Christensen Breakdown of academic impact, for papers by Andreas Evers Breakdown of academic impact, for papers by Antonella Ciancetta Breakdown of academic impact, for papers by Mario Cardozo Breakdown of academic impact, for papers by Christian Sköld
Rankless by CCL
2026